Matches in Nanopublications for { ?s ?p "[Individuals carrying both the CYP19A1 and KLK3 -252A>G variant alleles had a significantly increased risk for prostate cancer (OR, 2.87; 95% CI, 1.10-7.49; P = 0.03).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 10 of
10
with 100 items per page.
- assertion description "[Individuals carrying both the CYP19A1 and KLK3 -252A>G variant alleles had a significantly increased risk for prostate cancer (OR, 2.87; 95% CI, 1.10-7.49; P = 0.03).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Individuals carrying both the CYP19A1 and KLK3 -252A>G variant alleles had a significantly increased risk for prostate cancer (OR, 2.87; 95% CI, 1.10-7.49; P = 0.03).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Individuals carrying both the CYP19A1 and KLK3 -252A>G variant alleles had a significantly increased risk for prostate cancer (OR, 2.87; 95% CI, 1.10-7.49; P = 0.03).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Individuals carrying both the CYP19A1 and KLK3 -252A>G variant alleles had a significantly increased risk for prostate cancer (OR, 2.87; 95% CI, 1.10-7.49; P = 0.03).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP531765.RAWCqKNpRKwaRva90SXilrdmIva19C3vuHViiiQxQk1wE130_assertion description "[Individuals carrying both the CYP19A1 and KLK3 -252A>G variant alleles had a significantly increased risk for prostate cancer (OR, 2.87; 95% CI, 1.10-7.49; P = 0.03).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP531765.RAWCqKNpRKwaRva90SXilrdmIva19C3vuHViiiQxQk1wE130_provenance.
- NP531762.RAmMuoAxEey0yv-SDYjXalZRyX2sIjMPZ9eu8PA7Fyr1A130_assertion description "[Individuals carrying both the CYP19A1 and KLK3 -252A>G variant alleles had a significantly increased risk for prostate cancer (OR, 2.87; 95% CI, 1.10-7.49; P = 0.03).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP531762.RAmMuoAxEey0yv-SDYjXalZRyX2sIjMPZ9eu8PA7Fyr1A130_provenance.
- NP531766.RAuccWGGgVBdTtUEPKR8_8Qp1bpmnw_pF-KrC03unDnKQ130_assertion description "[Individuals carrying both the CYP19A1 and KLK3 -252A>G variant alleles had a significantly increased risk for prostate cancer (OR, 2.87; 95% CI, 1.10-7.49; P = 0.03).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP531766.RAuccWGGgVBdTtUEPKR8_8Qp1bpmnw_pF-KrC03unDnKQ130_provenance.
- NP531769.RAuWX1QNEMig7rMx7fLd7MOEH5CUvKR9CzOebUURxO2RE130_assertion description "[Individuals carrying both the CYP19A1 and KLK3 -252A>G variant alleles had a significantly increased risk for prostate cancer (OR, 2.87; 95% CI, 1.10-7.49; P = 0.03).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP531769.RAuWX1QNEMig7rMx7fLd7MOEH5CUvKR9CzOebUURxO2RE130_provenance.
- NP531764.RA0uYpTadpj-jcgquz92jNV42e24k6l5rmMtBPmhjvLGs130_assertion description "[Individuals carrying both the CYP19A1 and KLK3 -252A>G variant alleles had a significantly increased risk for prostate cancer (OR, 2.87; 95% CI, 1.10-7.49; P = 0.03).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP531764.RA0uYpTadpj-jcgquz92jNV42e24k6l5rmMtBPmhjvLGs130_provenance.
- NP531767.RA18r3zArStBR1b4RvfG8IpFbkdpFPepPnvdscig9V4_w130_assertion description "[Individuals carrying both the CYP19A1 and KLK3 -252A>G variant alleles had a significantly increased risk for prostate cancer (OR, 2.87; 95% CI, 1.10-7.49; P = 0.03).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP531767.RA18r3zArStBR1b4RvfG8IpFbkdpFPepPnvdscig9V4_w130_provenance.